Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cell Bio Human Tech Co. Ltd. (318160:KRX), powered by AI.
Cell Bio Human Tech Co. Ltd. is currently trading at ₩6,280. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Cell Bio Human Tech Co. Ltd. on Alpha Lenz.
Cell Bio Human Tech Co. Ltd.'s P/E ratio is 6.7.
“Cell Bio Human Tech Co. Ltd. trades at a P/E of 6.7 (undervalued) with strong ROE of 16.9%. 3Y revenue CAGR of 22.8% highlights clear growth momentum.”
Ask for details →Cell Bio Human Tech Co. Ltd. is a prominent entity in the biotechnology sector specializing in advanced healthcare and biomedical solutions. The primary function of this company is to innovate and manufacture cutting-edge biopharmaceutical products, focusing on addressing critical health challenges. It operates predominantly in the fields of cell therapy, regenerative medicine, and antibody technology, playing a pivotal role in advancing treatments for complex diseases. A notable feature of Cell Bio Human Tech Co. Ltd. is its emphasis on research and development, which propels the continuous discovery of novel medical interventions. The company's deep-rooted commitment to utilizing cell engineering and genetic technologies underlines its contribution to the advancement of precision medicine. In the financial market, Cell Bio Human Tech Co. Ltd. serves as a crucial player within the biotechnology industry. It reflects trends in biomedical innovation and investment flows in health technology, engaging with stakeholders ranging from healthcare professionals to investors keen on the future of medical treatments. Operating from its base in Asia, the company significantly impacts global health markets by providing solutions that contribute to the well-being of populations worldwide.
“Cell Bio Human Tech Co. Ltd. trades at a P/E of 6.7 (undervalued) with strong ROE of 16.9%. 3Y revenue CAGR of 22.8% highlights clear growth momentum.”
Ask for details →Cell Bio Human Tech Co. Ltd. (ticker: 318160) is a company listed on KRX in the Consumer Defensive sector (Household & Personal Products). It has approximately 58 employees. Market cap is $58.6B.
The current price is ₩6,280 with a P/E ratio of 6.72x and P/B of 1.03x.
ROE is 16.91% and operating margin is 18.25%. Annual revenue is $51.1B.